treatments for hr postmenopausal breast cancer
Published 2 years ago • 766 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
2:15
outlook for hr /her2- advanced breast cancer treatment
-
4:20
adjuvant treatment guidelines in post-menopausal women with breast cancer
-
6:23
alternate: fulvestrant and/or anastrozole in er her2- postmenopausal breast cancer
-
3:44
alternate: neoadjuvant endocrine treatment in er /her2- breast cancer
-
8:30
hr breast cancer: endocrine therapy, surgery and radiotherapy
-
8:18
endocrine therapy in premenopausal women with hr breast cancer
-
0:54
treatment de-escalation in premenopausal patients with hr /her2- breast cancer and micro-metastasis
-
5:28
capitello-291: capivasertib fulvestrant for ai-resistant hr /her2- advanced breast cancer
-
10:15
monaleesa-3 os results: fulvestrant/ribociclib in postmenopausal hr /her2- advanced breast cancer
-
4:03
monarche 4-year: abemaciclib endocrine therapy for hr , her2-, node-positive, high-risk early bc
-
1:24
treatments for estrogen-positive breast cancer
-
1:57
impact of cdk4/6 inhibitors on hr-positive, her2-negative advanced breast cancer
-
5:56
how to treat hormone receptor-positive (hr ) breast cancer: all you need to know
-
11:23
breast cancer treatment and menopause: a comprehensive guide
-
1:39
abemaciclib for hr /her2- advanced or metastatic breast cancer
-
3:12
combination treatments for premenopausal breast cancer: endocrine therapy and ovarian suppression
-
6:09
ki-67 index after neoadjuvant et as a prognostic biomarker for hr /her2- early breast cancer
-
5:14
adjuvant chemo omission feasible for certain postmenopausal breast cancer patients | kevin kalinsky
-
3:23
should chemotherapy be used in post-menopausal patients with low genomic risk hr breast cancer?